You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection

Catherine Jomary

Technology Lead ATMPs

Catherine Jomary Technology Lead ATMPs

"My passion is turning scientific dreams into medical reality."

Catherine has over 20 years’ experience in cell and gene therapy, regenerative medicine, pharmacology, biochemistry, molecular & cellular biology, within the academic, biotechnology, CDMO & pharmaceutical sectors.

She has managed pre-clinical, clinical and commercial phases cell and gene therapy programs (pre-clinical, technology process transfers, Phase I/II/III- product life cycle, comparability study, process and analytical qualification & validation, APV, raw materials testing, regulatory dossier: IMPD, IND), and commercial launch (process and analytical validation, regulatory dossier: MMA, BLA).

She has additional experience in product and process CMC life cycle management including commercial pre-launch, launch and post approval of cell and gene therapy products with significant regulatory experience (FDA, EMA and corporate GMP compliance audits; regulatory submission dossiers- IND, IMPD, BLA, and MMA).

She provides the interface between the customer, supply, quality, business development, operations, and regulatory to deliver and execute client contracts to manufacture cell and gene therapy products. Her experience extends to contract negotiations (quality technical agreement, project plans, budget, time planning and staffing) and she is an efficient communicator of complex issues, both orally and in written reports having authored a number of scientific papers and presented at conferences and symposiums.

  • PhD Molecular Pharmacology (First Class) University Paul Sabatier Toulouse, France
  • Master degree (First Class), Molecular Biology of Membranes and Cellular Interactions, University Paris VII, France
  • Bachelor degree in Biochemistry, University Paris VII, France
  • Society for Neuroscience, International Brain Research Organization
  • International Society for Pharmaceutical Engineering (ISPE)
  • Biogen
  • Lonza
  • Novartis
  • Takeda
  • Yposkesi
  • MeiraGTx Limited
  • Baxter Healthcare
  • Jomary, C. & Devlin , C. “The Challenges of Multiproduct Facility Design.” International Society for Pharmaceutical Engineering. May 2023.
  • Jomary, C. “Getting to Grips With mRNA - Walking Through the mRNA Manufacturing Process – and Its Many Challenges.” Medicine Maker. 30 November 2022.
  • Todorov, G & Jomary, C. “What Improvements Do We Need To See In Cell And Gene Supply Chains?” November, 1 2022.
  • Jomary, C. “Review Of mRNA Vaccines & Therapeutics Manufacturing Challenges: Plasmid DNA Manufacturing.” June 7, 2022.
  • “mRNA Vaccines- An overview of the manufacturing challenges and bottlenecks”, PDA Ireland - ATMP Hybrid Conference, Dublin, Ireland November 2021
  • “Differentiation of Rat Hair Follicle Stem Cells into Photoreceptor.” Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, Florida, May 2010.
  • “From Hair Follicle Stem Cells to Neuronal Cells”, Birmingham NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham, Birmingham UK, March 2012.

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.


We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.